Sacral neuromodulation; does it affect colonic transit time in patients with faecal incontinence?
- PMID: 16630237
- DOI: 10.1111/j.1463-1318.2005.00930.x
Sacral neuromodulation; does it affect colonic transit time in patients with faecal incontinence?
Abstract
Objective: Sacral neuromodulation (SNM) has been a successful treatment in urinary voiding disorders for years. A concomitant effect on bowel function was observed leading to the treatment of faecal incontinence with SNM. In this study we describe the effect of SNM on bowel frequency and (segmental) colonic transit time.
Patients and methods: Fourteen patients with faecal incontinence who qualified for permanent SNM underwent a colon transit study before and one month after permanent implant. Patients completed a three-week bowel habits diary before and during stimulation.
Results: Median incontinence episodes and days per week before SNM were, 8.7 and 4.2, respectively, and both decreased significantly to 0.67 (P = 0001) and 0.5 (P = 0001) during trial screening and to 0.33 (P = 0001) and 0.33 (P = 0001) after permanent implant. The median number of bowel movements per week decreased from 14.7 (6.7-41.7) to 10.0 (3.7-22.7)(P = 0005) during trial screening and to 10.0 (6.0-24.3)(P = 0008) during permanent stimulation. Resting and squeeze pressures did not change significantly during stimulation. Segmental colonic transit time before and during stimulation for right colon, left colon and recto sigmoid were, respectively, 6 (0-25) vs 5 (0-16) hours, 2 (0-29) vs 4 (0-45) hours and 7 (28) vs 8 (0-23) hours. No significant changes were found in both segmental and total colonic transit time; 17 (1-65) vs 25 (0-67) hours.
Conclusion: SNM in patients with fecal incontinence led to a significant decrease of bowel movements however (segmental) colonic transit time was not influenced.
Similar articles
-
Is a morphologically intact anal sphincter necessary for success with sacral nerve modulation in patients with faecal incontinence?Colorectal Dis. 2008 Mar;10(3):257-62. doi: 10.1111/j.1463-1318.2007.01375.x. Epub 2007 Oct 19. Colorectal Dis. 2008. PMID: 17949447
-
Sacral neuromodulation: long-term outcome and quality of life in patients with faecal incontinence.Colorectal Dis. 2011 Oct;13(10):1162-6. doi: 10.1111/j.1463-1318.2010.02447.x. Colorectal Dis. 2011. PMID: 20955512
-
Sacral neuromodulation in patients with faecal incontinence: results of the first 100 permanent implantations.Colorectal Dis. 2007 Oct;9(8):725-30. doi: 10.1111/j.1463-1318.2007.01241.x. Epub 2007 May 17. Colorectal Dis. 2007. PMID: 17509049 Clinical Trial.
-
Neuromodulation for functional bowel disorders.Best Pract Res Clin Gastroenterol. 2009;23(4):545-53. doi: 10.1016/j.bpg.2009.04.009. Best Pract Res Clin Gastroenterol. 2009. PMID: 19647689 Review.
-
The role of sacral neuromodulation in double incontinence.Colorectal Dis. 2011 Mar;13 Suppl 2:15-8. doi: 10.1111/j.1463-1318.2010.02520.x. Colorectal Dis. 2011. PMID: 21284797 Review.
Cited by
-
Bowel management for the treatment of pediatric fecal incontinence.Pediatr Surg Int. 2009 Dec;25(12):1027-42. doi: 10.1007/s00383-009-2502-z. Epub 2009 Oct 15. Pediatr Surg Int. 2009. PMID: 19830436 Free PMC article. Review.
-
Systematic review of the impact of sacral neuromodulation on clinical symptoms and gastrointestinal physiology.ANZ J Surg. 2016 Apr;86(4):232-6. doi: 10.1111/ans.13257. Epub 2015 Aug 5. ANZ J Surg. 2016. PMID: 26245170 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources